Monthly Archives: February 2019

Researchers: Gene Involved in ADHD Could Be Related to Addictive Substance Use – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Researchers: Gene Involved in ADHD Could Be Related to Addictive Substance Use – APhA submits compounding comments to FDA. – (866) 348-2889. An international study of around 2,700 children, adolescents, and adults … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Dupilumab Improved Outcomes in Patients With Chronic Rhinosinusitis, Nasal Polyps – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Dupilumab Improved Outcomes in Patients With Chronic Rhinosinusitis, Nasal Polyps – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 A pair of phase 3 trials have demonstrated that … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Approves TAS-102 for Treating Adults With Gastric/GEJ Cancer – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Approves TAS-102 for Treating Adults With Gastric/GEJ Cancer – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the FDA have approved trifluridine/tipiracil (Lonsurf, Taiho Oncology), also known as … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Officials Advance Sunscreen Regulations – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Officials Advance Sunscreen Regulations – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Officials with the US FDA this week issued a proposed rule that would update regulatory … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Influenza Vaccine Efficacy May Be Reduced in Older Adults – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Influenza Vaccine Efficacy May Be Reduced in Older Adults – APhA submits compounding comments to FDA. – (866) 348-2889. Influenza vaccines may be less effective in the elderly due to a lack … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Accepts sNDA for AML Therapy – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Accepts sNDA for AML Therapy – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 The FDA has accepted a supplemental New Drug Application (sNDA) for ivosidenib (Tibsovo, … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Respiratory Inhaler for Delivering Cannabinoids Receives ISO Certification – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Respiratory Inhaler for Delivering Cannabinoids Receives ISO Certification – APhA submits compounding comments to FDA. – (866) 348-2889. A Senzer medical device for delivering pharmaceutical-grade cannabinoids has been granted ISO certification for … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

New Treatment for Hemophilia A Receives FDA Approval – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF New Treatment for Hemophilia A Receives FDA Approval – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 The FDA has approved the Biologics License Application for Novo Nordisk’s … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Study Demonstrates Accuracy in Blood Glucose Test Strip – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Study Demonstrates Accuracy in Blood Glucose Test Strip – APhA submits compounding comments to FDA. – (866) 348-2889. A study published recently in the Journal of Diabetes Science and Technology (JDST) evaluated the accuracy of … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Pembrolizumab, Axitinib Combo for Advanced Kidney Cancer Granted Priority Review Designation – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Pembrolizumab, Axitinib Combo for Advanced Kidney Cancer Granted Priority Review Designation – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Officials with the FDA have granted Priority Review … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off